| Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy (NCT03332784) | Takeda | 2017-11-04 |
| A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia (NCT03330691) | Seattle Children's Hospital | 2017-11-03 |
| huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia (NCT03103971) | Fred Hutchinson Cancer Center | 2017-11-03 |
| A Double-blind Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo (NCT03333538) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2017-11-03 |
| Clinical Study to Investigate the Effect of Macitentan on the Concentrations of Rosuvastatin in the Blood of Healthy Male Subjects (NCT03359291) | Actelion | 2017-11-03 |
| Combination of Gatipotuzumab and Tomuzotuximab in Patients With Solid Tumors (NCT03360734) | Glycotope GmbH | 2017-11-02 |
| A Phase 1 Study of Intraoperative Administration of CA-008 for the Correction of Hallux Valgus Deformity (NCT03307837) | Concentric Analgesics | 2017-11-02 |
| Efectiveness of Donor IL-15-stimulated NK Cells Post Transplant Infusion in in Acute Leukemia (NCT03669172) | Martín, José Luis Díez, M.D. | 2017-11-02 |
| Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight (NCT04320771) | Bayer | 2017-11-02 |
| Drug-drug Interaction Study of FYU-981 and Oxaprozin (NCT03350386) | Mochida Pharmaceutical Company, Ltd. | 2017-11-02 |
| A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis (NCT03329885) | Bristol-Myers Squibb | 2017-11-02 |
| [KJ-INT-002] BE Study (NCT03509831) | Kukje Pharma | 2017-11-02 |
| This Study in Healthy Men Tests How Different Doses of BI 894416 Are Taken up in the Body and How Well BI 894416 is Tolerated (NCT03315936) | Boehringer Ingelheim | 2017-11-02 |
| Safety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer (NCT03307629) | Noxopharm Limited | 2017-11-01 |
| CD19 CAR and PD-1 Knockout Engineered T Cells for CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma (NCT03298828) | Third Military Medical University | 2017-11-01 |
| Reduction of Pro-Inflammatory Synovial Fluid Biomarkers in Osteoarthritis of the Knee With Alpha-2 Macroglobulin (NCT03656575) | NYU Langone Health | 2017-11-01 |
| Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of Nursing (NCT03279536) | Woman's Health University Hospital, Egypt | 2017-11-01 |
| Nitrite in Hypertrophic Cardiomyopathy (HCM) Study (NCT03251287) | University of East Anglia | 2017-11-01 |
| Pars Plana Ex-Press Shunt in Vitrectomized Eyes (NCT03605823) | Cairo University | 2017-11-01 |
| Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency (NCT03346967) | Vinmec Research Institute of Stem Cell and Gene Technology | 2017-11-01 |
| A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma (NCT03234595) | Everfront Biotech Co., Ltd. | 2017-11-01 |
| Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen (NCT03081910) | Baylor College of Medicine | 2017-11-01 |
| TMTP1-ICG Mapping in Colposcopy-directed Biopsy (NCT03321461) | Huazhong University of Science and Technology | 2017-11-01 |
| Effects of Stress and Drug-cue Exposure (SCM) (NCT03154567) | Wayne State University | 2017-11-01 |
| Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Injuries in Children (NCT03147690) | David Mooney | 2017-11-01 |
| the Effects of YangXinShi (YXS) on the Quality of Life and Exercise Tolerance in Patients With Chronic Heart Failure (NCT03333499) | Dalian University | 2017-11-01 |
| Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication (NCT03318484) | First Affiliated Hospital of Harbin Medical University | 2017-11-01 |
| Study to Evaluate the Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Upper or Lower Extremity Muscles Most Affected in Subjects With ALS (NCT03338114) | Flex Pharma, Inc. | 2017-11-01 |
| Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules. (NCT03319043) | Shanghai University of Traditional Chinese Medicine | 2017-11-01 |
| Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer (NCT03126812) | The Netherlands Cancer Institute | 2017-11-01 |
| Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease (NCT02611167) | The University of Texas Health Science Center, Houston | 2017-11-01 |
| Psilocybin for the Treatment of Migraine Headache (NCT03341689) | Yale University | 2017-11-01 |
| Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Capsular Resection Versus Capsular Flap Retention (NCT02970253) | ZOL | 2017-11-01 |
| Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn (NCT04328636) | Sohag University | 2017-11-01 |
| Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes (NCT03343782) | Vinmec Research Institute of Stem Cell and Gene Technology | 2017-11-01 |
| A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA (NCT03124498) | Chuan An Biotechnology Co., Ltd. | 2017-11-01 |
| ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study (NCT03082690) | Johns Hopkins University | 2017-11-01 |
| PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors (NCT03284723) | Pfizer | 2017-11-01 |
| Self-Management for Persistent Subacromial Pain (NCT04190836) | Oslo Metropolitan University | 2017-11-01 |
| Inorganic NItrate and EXercise Performance in Heart Failure (iNIX-HF): Dose Response (NCT02797184) | Washington University School of Medicine | 2017-10-31 |
| Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma (NCT03200847) | University of Colorado, Denver | 2017-10-31 |
| Prevention of Noise-induced Hearing Loss (NCT02049073) | Washington University School of Medicine | 2017-10-31 |
| Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers (NCT03312777) | Syntrix Biosystems, Inc. | 2017-10-31 |
| CED With Irinotecan Liposome Injection Using Real Time Imaging in Children With Diffuse Intrinsic Pontine Glioma (DIPG) (PNOC 009) (NCT03086616) | Sabine Mueller, MD, PhD | 2017-10-31 |
| Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression (NCT02675556) | Joshua M Hare | 2017-10-31 |
| Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation (NCT03065387) | M.D. Anderson Cancer Center | 2017-10-31 |
| Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14 (NCT03404856) | Orpha Labs | 2017-10-31 |
| A Study of BCD-135 in Patients With Advanced Solid Tumors (NCT03464032) | Biocad | 2017-10-31 |
| Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects (NCT03456388) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2017-10-30 |
| Combined LDR Boost and HDR Whole Gland (NCT03323879) | Sunnybrook Health Sciences Centre | 2017-10-30 |
| 4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer (NCT03364348) | George W. Sledge Jr. | 2017-10-30 |
| Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759 (NCT03360929) | LYZZ Alpha Holding Ltd | 2017-10-30 |
| Understanding GWI: Integrative Modeling (NCT04255498) | South Florida Veterans Affairs Foundation for Research and Education | 2017-10-30 |
| Study to Evaluate the Safety, PK, and Pharmacodynamics of LIB003 (NCT03545438) | LIB Therapeutics LLC | 2017-10-30 |
| A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept® (NCT03259958) | Corium, Inc. | 2017-10-30 |
| A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin (NCT03339752) | Idorsia Pharmaceuticals Ltd. | 2017-10-30 |
| A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects (NCT03239379) | Bioniz Therapeutics | 2017-10-30 |
| U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer (NCT03260491) | Daiichi Sankyo | 2017-10-30 |
| Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL (NCT03319901) | Dana-Farber Cancer Institute | 2017-10-30 |
| An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab (NCT03167437) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-10-30 |
| Intra-individual Reproducibility in Nerve Block Duration (NCT03310047) | Nordsjaellands Hospital | 2017-10-30 |
| Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer (NCT03104595) | Enzychem Lifesciences Corporation | 2017-10-30 |
| A Study to Assess Therapeutic Equivalence Between Test EMLA Patch With Marketed EMLA Patch in Healthy Subjects. (NCT03313336) | AstraZeneca | 2017-10-30 |
| Bioavailability Study of K0706 in Healthy Subjects (NCT03316820) | Sun Pharma Advanced Research Company Limited | 2017-10-28 |
| A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects (NCT03235375) | MedImmune LLC | 2017-10-27 |
| AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology Studies (NCT03313557) | AstraZeneca | 2017-10-27 |
| A Study of Multiple Doses of LY3305677 in Healthy Participants (NCT03325387) | Eli Lilly and Company | 2017-10-27 |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology (NCT03330028) | M.D. Anderson Cancer Center | 2017-10-27 |
| Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer (NCT03325634) | University of Colorado, Denver | 2017-10-27 |
| A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers (NCT03273842) | Pfizer | 2017-10-27 |
| MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI) (NCT02865616) | NuBiyota | 2017-10-27 |
| Bioavailability of KBP-5074 Tablet vs Capsule Formulations (NCT03340753) | KBP Biosciences | 2017-10-26 |
| Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (NCT03239483) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-10-26 |
| SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC) (NCT03050554) | Andrew Sharabi | 2017-10-26 |
| Relative Bioavailability Study of Emodepside IR-tablets and Solution (NCT03383523) | Drugs for Neglected Diseases | 2017-10-26 |
| Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia (NCT02879695) | National Cancer Institute (NCI) | 2017-10-25 |
| CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors (NCT03113188) | CanBas Co. Ltd. | 2017-10-25 |
| This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men (NCT03307252) | Boehringer Ingelheim | 2017-10-25 |
| Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus (NCT03332836) | Hanmi Pharmaceutical Company Limited | 2017-10-25 |
| Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults (NCT03186781) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-10-25 |
| Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer (NCT02977468) | Eileen Connolly | 2017-10-25 |
| Evaluation of TTP399 in Patients With Type 1 Diabetes (NCT03335371) | vTv Therapeutics | 2017-10-25 |
| Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma (NCT03309111) | Ichnos Sciences SA | 2017-10-25 |
| An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007 (NCT04168957) | Athenex, Inc. | 2017-10-25 |
| Molar Potency Study of HM12460A in Healthy Subjects (NCT03330314) | Hanmi Pharmaceutical Company Limited | 2017-10-24 |
| A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS) (NCT03283267) | AstraZeneca | 2017-10-24 |
| Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects (NCT03139305) | AdventHealth Translational Research Institute | 2017-10-24 |
| Role of Sympathetic Vasoconstriction on Insulin-Mediated Microvascular Recruitment and Glucose Uptake in Obesity (NCT03318094) | Vanderbilt University Medical Center | 2017-10-24 |
| A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers (NCT03279237) | Massachusetts General Hospital | 2017-10-24 |
| Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies (NCT03263637) | AstraZeneca | 2017-10-24 |
| Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cancer (NCT03645148) | Zhejiang Provincial People's Hospital | 2017-10-24 |
| 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia (NCT03128034) | Fred Hutchinson Cancer Center | 2017-10-24 |
| VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers (NCT03332732) | Venatorx Pharmaceuticals, Inc. | 2017-10-24 |
| A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics (NCT03776968) | Hinova Pharmaceuticals Inc. | 2017-10-24 |
| Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant (NCT03068819) | Washington University School of Medicine | 2017-10-23 |
| A Study in Healthy Japanese and Caucasian Subjects to Assess the Pharmacokinetics, Safety and Tolerability of Risankizumab (NCT05305222) | AbbVie | 2017-10-23 |
| The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People (NCT03255993) | Shanghai Pharmaceuticals Holding Co., Ltd | 2017-10-23 |
| A Study of CCX168 in Japanese and Caucasian Healthy Adult Males (NCT05988008) | Amgen | 2017-10-23 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945 (NCT02715570) | Pulmocide Ltd | 2017-10-23 |
| Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Breast Cancer (NCT03088527) | Stemline Therapeutics, Inc. | 2017-10-23 |